<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Barr EA</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NIAID NIH HHS</funding><pubmed_abstract>&lt;i>Background:&lt;/i> Primary results of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) 2002 trial showed that cognitive behavioural therapy (CBT) and medication management algorithm (MMA) (COMB-R) significantly improved depression in youth with HIV (YWH) compared with enhanced standard care (ESC). Acceptability and satisfaction were examined among study participants and clinicians.&lt;i>Method:&lt;/i> Between March 2017 and March 2019, 13 U.S. sites enrolled YWH, aged 12-24, diagnosed with nonpsychotic depression. Sites were randomised to either COMB-R (CBT by a therapist and licensed prescriber) or ESC (standard psychotherapy and medication management). After the intervention (week 24), participants, prescribers, and therapists rated acceptability and satis</pubmed_abstract><journal>Journal of child and adolescent mental health</journal><pagination>1-16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12439113</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV.</pubmed_title><pmcid>PMC12439113</pmcid><funding_grant_id>UM1 AI068632</funding_grant_id><funding_grant_id>UM1 AI106716</funding_grant_id><funding_grant_id>P30 AI042853</funding_grant_id><funding_grant_id>HHSN275201800001I</funding_grant_id><funding_grant_id>UM1 AI068616</funding_grant_id><funding_grant_id>UM1AI068616-15 (IMPAACT SDMC)</funding_grant_id><pubmed_authors>Townley E</pubmed_authors><pubmed_authors>Barr EA</pubmed_authors><pubmed_authors>Kennard BD</pubmed_authors><pubmed_authors>Emslie GJ</pubmed_authors><pubmed_authors>Knowles K</pubmed_authors><pubmed_authors>Buisson S</pubmed_authors><pubmed_authors>Deville JG</pubmed_authors><pubmed_authors>Shapiro DE</pubmed_authors><pubmed_authors>Bergam L</pubmed_authors><pubmed_authors>Shikora M</pubmed_authors><pubmed_authors>Brown LK</pubmed_authors><pubmed_authors>Krotje C</pubmed_authors><pubmed_authors>Gillespie SL</pubmed_authors><pubmed_authors>Baltrusaitis K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV.</name><description>&lt;i>Background:&lt;/i> Primary results of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) 2002 trial showed that cognitive behavioural therapy (CBT) and medication management algorithm (MMA) (COMB-R) significantly improved depression in youth with HIV (YWH) compared with enhanced standard care (ESC). Acceptability and satisfaction were examined among study participants and clinicians.&lt;i>Method:&lt;/i> Between March 2017 and March 2019, 13 U.S. sites enrolled YWH, aged 12-24, diagnosed with nonpsychotic depression. Sites were randomised to either COMB-R (CBT by a therapist and licensed prescriber) or ESC (standard psychotherapy and medication management). After the intervention (week 24), participants, prescribers, and therapists rated acceptability and satis</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-01T15:49:26.975Z</modification><creation>2026-04-08T13:49:00.8Z</creation></dates><accession>S-EPMC12439113</accession><cross_references><pubmed>39550758</pubmed><doi>10.2989/17280583.2024.2387632</doi></cross_references></HashMap>